Clinical Features of 705 Borrelia burgdorferi Seropositive

Patients in an Endemic Area of Northern Italy by Stinco, Giuseppe et al.
Research Article
Clinical Features of 705 Borrelia burgdorferi Seropositive
Patients in an Endemic Area of Northern Italy
Giuseppe Stinco,1 Maurizio Ruscio,2 Serena Bergamo,1
Davide Trotter,1 and Pasquale Patrone1
1 Department of Clinical and Experimental Pathology and Medicine, Institute of Dermatology, University of Udine School of Medicin,
Ospedale “San Michele,” Piazza Rodolone 1, Gemona del Friuli, 33013 Udine, Italy
2 Clinical Laboratory and Microbiology Department, Hospital of San Daniele del Friuli, San Daniele, Italy
Correspondence should be addressed to Giuseppe Stinco; giuseppe.stinco@uniud.it
Received 26 August 2013; Accepted 22 October 2013; Published 16 January 2014
Academic Editors: Y. Asano and U. Wollina
Copyright © 2014 Giuseppe Stinco et al.This is an open access article distributed under theCreativeCommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. Lyme Borreliosis is a multisystemic infection caused by spirochetes of Borrelia burgdorferi sensu lato complex.
The features of Lyme Borreliosis may differ in the various geographical areas, primarily between the manifestations found in
America and those found in Europe and Asia. Objective. to describe the clinical features of Lyme Borreliosis in an endemic
geographic area such as Friuli-Venezia Giulia in the Northeastern part of Italy. Methods. The medical records of patients resulted
seropositive for Borrelia burgdorferi have been retrospectively recorded and analyzed. Results. Seven hundred and five patients met
the inclusion criteria, 363males and 342 females. Erythemamigrans was themost commonmanifestation, detected in 437 patients.
Other classical cutaneous manifestations included 58 cases of multiple erythema migrans, 7 lymphadenosis benigna cutis, and 18
acrodermatitis chronica atrophicans. The musculoskeletal system was involved in 511 patients. Four hundred and sixty patients
presented a neurological involvement. Flu-like symptoms preceded or accompanied or were the only clinical feature in 119 patients.
Comments. The manifestations of Lyme borreliosis recorded in this study are similar to the ones of other endemic areas in Europe,
even if there are some peculiar features which are different from those reported in Northern Europe and in the USA.
1. Introduction
Lyme Borreliosis (LB) is a complex multisystemic infection
that involves the skin, joints, nervous system, eyes, and heart,
caused by spirochetes of the Borrelia burgdorferi (Bb) sensu
lato complex, which are transmitted primarily by Ixodid ticks.
After the transmission of the spirochete, human LB generally
occurs in stages, with different clinical manifestations and
evolution [1, 2]. The features of LB may be different in some
aspects in the various geographical areas, primarily as regards
the manifestations found in America and those found in
Europe and Asia [3, 4]. The prevalence of erythema migrans
(EM) is similar in theUSA andNorthern Europe, but lower in
Southern Europe [3–5]. Acrodermatitis chronica atrophicans
(ACA), borrelial lymphadenosis benigna cutis (LABC), and
some manifestations of carditis have been detected almost
exclusively in Europe [3–6]. Articular involvement seems to
be more frequent in the USA than in Europe, where arthritis
is more frequent in Southern countries rather than in the
North [3]. Neurological damage is more often observed in
European countries, whereas in North America milder forms
were reported [3]. It may be supposed that even in Europe the
main clinical features of LB can be different in some aspects.
These assumptions prompted us to carry out a retrospective
study aimed at assessing the clinical features of LB in an
endemic geographic area as Friuli Venezia Giulia, in order
to define and recognize the clinical presentations and the
evolution of the disease in these lands and consequently
to describe whether there are differences in the clinical
presentations compared to those found in other areas of the
world.
2. Materials and Methods
Every case history of each patient addressing to the regional
reference centre for Lyme disease in San Daniele del Friuli
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from June 2004 to June 2010 has been retrospectively
recorded and analysed. The medical records of patients that
resulted seropositive for Bb and followed during the whole
course of their disease were recruited. Patients who presented
the following criteria have been excluded from the study:
wrong diagnoses (not LB), seropositive patients who did not
present any typical or occasionally associated manifestation
of LB, seronegative patients, patients who did not report
to the planned visits, subjects with EM without any other
symptomwho have been treated and cured and/or whomade
no serology test or seroconversion, and patients who made a
prophylactic treatment after the tick bite or who were taking
drugs that might have interfered with laboratory tests or
could have hidden the clinical manifestations of LB.
Out of the 2000 analysed case histories, 705 met the
inclusion criteria and were recruited in this survey. All of the
subjects were resident in Friuli Venezia Giulia.
The ELISA (Enzyme-Linked Immunosorbent Assay)
IgM/IgG and Western blot (IgM/IgG immunoblots if early
disease was suspected; IgG Western blot alone if late dis-
ease was suspected) were performed to define seropositive
patients, using the same kit in the same laboratory. Other
laboratory and instrumental tests, such as tissue biopsy,
culture, polymerase chain reaction (PCR), cerebrospinal fluid
examination, sinovial liquid examination, haemochrome,
liver function tests, ECG, X-rays, electromyography, and
magnetic resonance, have been taken into account, particu-
larly for the doubtful cases.
3. Results
Seven hundred andfivemedical records fulfilled the inclusion
criteria, and thus were recorded and analysed in this study,
including 363 males and 342 females, with a male to female
ratio of 1.06.Themean age of the whole survey was 44.7 years,
ranging from 4 to 86 years; 67 were under 16 years; 382 were
between 16 and 60 years; 256 were over 60 years.
The clinical manifestations observed in the 705 patients
seropositive for Bb have been summarized in Table 1.
There have been 536 (76.03%) cutaneous forms of LB
recorded. EM was the most common manifestation and it
has been detected in 437 patients (61.99%).There was neither
gender difference (M : F = 215 : 222) nor age difference. EM
has been found during the visit in 319 patients and it was
reported by 118 subjects as an history fact. It appeared from
3 to 25 days after the tick bite (average: after 12 days). Other
classical cutaneous manifestations of LB included 58 cases of
multiple EM (8.23%), 7 LABC (1%), and 18 ACA (2.55%).
Atypical cutaneous manifestations, that is, clinical features
not surely linked to LB, were 16 (2.27%), in details: 8 cases of
morphoea, 2 Raynaud’s phenomenon, 1 lichen sclerosus and
atrophicus, 1 pityriasis lichenoides, 1 Gilbert’s pityriasis rosea,
1 urticaria, 1 anetoderma, and 1 erythema nodosum.
The musculoskeletal system was involved in 511 patients
(72.48%): 262 out of 511 presented arthralgias or acute arthri-
tis; they were 119men and 143 women; 88 had a single episode
whereas 174 suffered from several attacks. The evolution to
chronic arthritis was seen in 22 cases (8% among the patients
Table 1: The clinical manifestations observed in the 705 patients
seropositive for Borrelia burgdorferi.
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Musculoskeletal 511
Nervous system 460
Psychae 37
Eye 71
Heart 57
Liver 41
Flu-like 119
with arthralgias/acute arthritis). Muscular hypotonia and/or
hypotrophy was observed in 41 patients (5.81%).
Four hundred and sixty patients presented a neurolog-
ical involvement. Two patients reported Bannwarth’s syn-
drome, 3 acute encephalopathy and 1 chronic encephalopa-
thy. Two hundred and ninety-three patients (41.56%), 127
males and 166 females, reported cephalea, dizziness, memory
and concentration problems, irritability, emotional lability,
and sleepiness. As far as the peripheral nervous system
is concerned, 161 patients (22.84%) reported paresthesias
(115 cases), sensitiveness disorders (47 patients), and motion
functionality disorders (19 cases). Out of these 161 patients, 74
suffered from neuritis, polyneuritis, meningoradiculitis and
peripheral nerves paralysis, in particular there were 12 cases
of the seventh cranial nerve paralysis.
Flu-like symptoms such as fever, arthromyalgia and
headache preceded or accompanied or were the only clinical
feature in 119 (16.88%) patients. Fever was the only symp-
tom in 11 patients (1.56%) while in 165 (23.4%) cases was
accompanied by other manifestations. A reactive regional or
generalized lymphadenopathy was recorded in 75 patients
(10.64%).
Psychiatric symptoms have been observed in 37 patients
(5.25%), 22 men and 15 women. There were 21 cases of
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anxiety, 10 cases of depression and 6 complex syndromes
characterised by panic attacks and phobias.
An intrinsic ocular disease or a disturb deriving from
the neuromuscular involvement of the eye has been observed
in 71 patients (10.07%), 25 males and 46 females: 28 cases
of conjunctivitis, 7 cases of photophobia, 13 cases of visual
impairment, 11 of bulbar pain, 4 of diplopia, 1 case of hemi-
anopsia, 1 of orbital muscle tremor, 3 cases of lacrimation and
burning and 3 of orbital oedema.
In 57 subjects (8.08%), 26 men and 31 women, there was
an involvement of the cardio-vascular system: 14 patients
suffered from tachycardia, 3 from bradycardia, and 13 from
palpitations. Twenty-four patients presented with the acute
onset of varying degrees of intermittent atrioventricular
heart block, symptomatic or detected by the ECG. A case
of complete atrioventricular block required the implant of
a pacemaker. One patient referred angina and 2 patients
suffered from a myocarditis.
An involvement of the liver was observed in 41 patients
of this survey (5.81) who reported specific alterations of the
cytonecrosis enzymes.
With the purpose of better investigating the severity
spectrum of LB, an analysis of the summation of the number
of symptoms per patient was made. Two hundred and forty-
eight (35.1%) patients reported only 1 manifestation. Two
different symptoms were observed in 251 (35.6%) patients,
3 clinical features were recorded in 120 (17.0%) subjects, and
more than three clinical manifestations assignable to LB were
reported for 86 (12.1%) cases.
4. Discussion
Friuli Venezia Giulia is one of the endemic regions for LB
in Italy because of the wide spread of piedmont zones which
are full of underbrushes. Here the climatic, geographical, and
faunistic conditions can foster the proliferation of the hard
tick Ixodes ricinus and thus may represent an ideal ecosystem
for the spread of Bb [7].
People living in Friuli Venezia Giulia may get in contact
with the ticks over and over because the suspension of
agricultural activities has caused the wide spread of woody
areas.
In this study the seropositivity for Bb is seen in both
males and females and it occurs at every age, even if the
adults are more affected probably because they spend more
time, for working or leisure reasons, in such zones with a
thick vegetation. The observation that children are affected
from a lesser extent than adults may be a result of the
several campaigns of information for the prevention of LB
which took place in recent years in our region.Therefore, the
population has become very sensitive to this issue: people are
accustomed to watching their children back from picnics or
outdoor games in order to remove quickly the ticks.
Since the relatively high prevalence of antibodies against
Bb (5% to 25%) is seen even in healthy persons, depending
on their prior exposure to tick bites in their occupational
and leisure-time activities [8], in our study, to avoid over-
diagnoses, we excluded all seropositive subjects who did not
present any other symptom related with LB.
Figure 1: Erythema migrans.
Figure 2: Multiple erythema.
The manifestations of LB recorded in this study are sim-
ilar to the ones of other endemic areas in Europe, presenting
a widespread clinical expressivity, even if there are some
peculiar features which are different from those reported
in Northern Europe and mostly in the USA, proving the
existence of several genospecies of Bb differently distributed
throughout the various geographical areas [4–10].
A solitary EM lesion is the most frequent presentation of
LB and EMwas found to be the most commonmanifestation
in the population analysed. Its clinical characteristics resulted
similar to those reported in the Literature [2] (Figure 1). The
lower incidence in this survey has been foreseen because of
the exclusion of all the EM that has been treated and cured
before the seroconversion.
In the USA, EM is often accompanied by flu-like symp-
toms such as fever, malaise, fatigue, headache, myalgia, or
arthralgia, whether in Europe it more frequently represents
an indolent and localised lesion [2, 10]. Multiple EM seem to
bemore often seen inUSA (about 20%) than inEurope (about
10%) [11, 12]; in this study 58 cases (8.33%) have multiple EM
(Figure 2).
Data gathered about the other cutaneous features are
consistent with those found in literature. LABC is the typical
subacute cutaneous manifestation of early disseminated LB
(Figure 3). In endemic areas, its frequency is approximately
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Figure 3: Lymphadenosis benigna cutis.
Figure 4: Acrodermatitis chronica atrophicans.
1-2% and it is the most common kind of B-cell pseudolym-
phoma of the skin [1].
ACA is the typical cutaneous feature of late LB in Europe
(Figure 4). It has beendescribedmost of all in elderly patients,
especially women, and is frequently associated with extra-
cutaneous symptoms as reported in other Italian observations
[13]. In the United States, only very few cases have been
described, referring to imported forms usually [14]. B. afzelii
has been mostly associated with the development of ACA,
even if both B. garinii and Bb sensu stricto have been isolated
from specimens of ACA.
In this survey, we reported 16 patients presenting skin
manifestations considered as atypical forms of LB such as
lichen sclerosus and atrophicus, morphoea, and anetoderma
[1, 15–18]. These manifestations have been more frequently
observed in Europe than in theUSA although this association
remains a controversial topic [15–19].
In untreated LB the joint manifestations can arise months
to years after the tick bite, usually in the form of a
chronic mono or asymmetrical oligoarthritis. In our series
the musculoskeletal involvement appears to be frequent. A
not very painful arthritis characterized by brief attacks of
joint swelling (Figure 5) was observed with an incidence
comparable to Northern America data [19]. The percentage
of acute arthritis evolved in chronic arthritis recorded in this
Figure 5: Articular involvement in Lyme borreliosis.
survey is similar to the one of other endemic areas in Europe
[20].
Manifestations of acute peripheral nervous
system involvement in LB include cranial neuropathy
(peripheral 7th nerve palsy), eventually associated with
radiculopathy (“Garin-Boujadoux-Bannwarth” syndrome)
or radiculoneuritis (acute onset of severe localised radicular
pain and/or motor weakness with or without sensory loss)
[21]. In stage 3, irreversible neurological damage is present
and the course of the illness is not self-limited. Chronic
progressive meningoencephalitis, characterized by spastic
paraparesis, cranial neuropathy, or cognitive impairment
has been reported in Europe, while Lyme encephalopathy,
a mild, late neurologic syndrome manifested primarily by
subtle cognitive disturbances, has been reported in the
United States [19, 20].
Our data demonstrated that the nervous system has
been involved in 65.24% of the analysed population, also
presenting severe forms, according to the data recorded in
Europe. In Europe, the frequency of neuroborreliosis seems
higher, potentially due to the greater neurotropism of B
garinii, which has not been isolated in North America [3].
There is much controversy about whether Bb infection
can cause psychiatric disease. In this survey, psychiatric
manifestations seem to be quite frequent, but these data are
comparable to those recorded in other endemic areas in
Europe and can be explained by the high tropism of Bb sensu
lato for the nervous system, in particular it can cause both a
transitory and a permanent damage of the limbus, which is
referred to the personal moods and behaviours [3].
Ocular involvement in LB, possible at every stage of the
disease, is most frequently reported in European patients
in the late phases of the disease [22, 23]. In this study the
involvement of the eye has been reported in 10.07% of the
patients, especially in women.
As reported in literature, the cardiac manifestations
tend to appear one week to seven months after the tick
bite (median, 21 days). Borrelial carditis is a relatively rare
complication in Europe, occurring in about 1% of all cases (in
contrast to 4–10% of North America) [20–24]. In our survey,
8.8% of patients reported symptomatic cardiac involvement
associated with Bb seropositivity often accompanied by other
manifestations, such as EM or neurological deficits. The high
number of heart disease found in our seriesmay be connected
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to the main limitation of our study, the recruitment of
seropositive patients that can undoubtedly lead to over-
diagnosis of LB. It is well known that the persistence of anti-
bodies is common and it can usually be misconstrued as an
evidence of florid infection. It is possible that symptoms such
as dizziness, palpitations, or syncope, caused by disturbances
of intracardiac impulse generation or impulse conduction
and which usually resolve in few weeks, may be considered
a coincidental finding in our patients.
Fever was detected in about 25% of the medical records
analysed. In Europe the borrelial infection tends to remain
localized for a long time without developing severe systemic
symptoms and fever is often described during the prodromic
phase. Otherwise in Northern America, flu-like symptoms,
including fever, may accompany the early cutaneous lesions
or can be the first manifestation of the disease. Such differ-
ences may be likely caused by the higher capacity of haematic
dissemination of Bb serotypes found in the New Continent.
Data about the prevalence of the fever gathered in this
survey are consistent; however, the possibility of coinfections
by other bacteria, viruses, and protozoa which can also be
transmitted by a tick bite must be taken into account in order
to reduce the role of Bb in the pathogenesis of the fevers
observed [25].
In 5.81% of the patients, laboratory tests showed a high
value of liver cyte-necrosis enzymes. Hepatic involvement is
not usually a typical characteristic of LB, even if in literature
sporadic cases of hepatitis are described [3]. Nevertheless, the
alteration of hepatic enzymes in more than 5% of the samples
examinated is still a very high record: even in this situation
there may be a coinfection transmitted by a tick-bite. It can
be assumed that the transaminase increasing can be caused by
a coinfection of Anaplasma phagocytophila, in which hepatic
alterations are more common [26].
This survey provides a detailed picture of the various
clinical features described during the different stages of Bb
infection in seropositive patients living in Friuli Venezia
Giulia.
The main limit of the study is that it has been performed
on a sample of seropositive patients that could mean a
mixture of patients with active Bb infection, immunological
memory, or nonspecific cross-reactivity. For this reason our
criteria of selection were very close: the diagnosis of LB is
mainly clinical, therefore clinical criteria (history, symptoms,
and signs) resulted decisive for the assignment of the diagno-
sis and the interpretation of the serological findings. Anyway,
in our results this bias must have been taken into account.
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